Leju Finance Deng RufeiOn December 21, it was reported that Zhuhai Deere Bioengineering Co., Ltd. (hereinafter referred to as "Deere Bio") was registered with the Guangdong Securities Regulatory Bureau yesterday, and the counseling agency was China Merchants Co., Ltd
According to the official website, Deere Biotech has been committed to the scientific research, production, sales and service of clinical microbial diagnostic products, and is a professional supplier of clinical microbial testing application products. The products are exported to more than 40 countries and regions, serving more than 5,000 medical institutions at home and abroad.
Deere Biotech was established on January 8, 2003, the legal representative is Lin Huaqing, the registered capital is 30 million yuan, and the business scope is the research and development of medical devices and biotechnology (excluding genetically modified technology, except for restrictions) and related technical servicesR&D, sales and related technical services of medical software. The company's major shareholder is Lin Huaqing, holding 6732%。At present, the company has 3 foreign investment enterprises, including Zhuhai Deere Biotechnology*** and so on.
The company's customers include Sichuan Lerong Innovative Medical Technology, Jiangxi Xinlvkang Medical Equipment, Nanjing Jingchuan Medical Equipment, etc.
According to Deere Biotech's 2023 semi-annual report, Deere Biotech's operating income in the first half of 2023 was 9629390,000 yuan, a year-on-year increase of 3403%；Net profit attributable to shareholders of the listed company was 1843510,000 yuan, a year-on-year increase of 6442%。